DIDariush Ilghari

Dariush Ilghari

*This is an algorithmically generated author record based on publicly available information.

Dariush Ilghari has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Abolfazl Ahmadi

    Faculty of New Technologies Iran University of Science and Technology Tehran Iran

    1 shared publication
  • Babak Mamnoon

    Pharmaceutical Sciences Department, North Dakota State University, Fargo, North Dakota 58105, United States

    1 shared publication
  • Farhad Khabbaz

    Department of Biochemistry and Genetic Qazvin University of Medical Sciences Qazvin IR Iran

    1 shared publication
  • Hossein Piri

    Department of Biochemistry and Genetic Qazvin University of Medical Sciences Qazvin IR Iran

    1 shared publication
  • Hossein Piri

    Cellular and Molecular Research Center, Research Institute for Prevention of Non Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran

    1 shared publication
  • Kamahldin Haghbeen

    Biochemistry and Biophysics Department, National Institute for Genetic Engineering and Biotechnology, Tehran, Iran

    1 shared publication

Latest Publications

  • Open Access

    When Do Tourists Defend Tourism Service Providers’ Reputations? Insights from Attribution Theory

    by Mahmoud Ibraheam Saleh, Shahin Amiri, Dariush Ilghari, Lawahidh Fadhil Ali Hasham, Hossein Piri

    The respiratory symptoms of acute respiratory distress syndrome (ARDS) in the coronavirus disease 2019 (COVID-19) patients is associated with accumulation


    • 1 February 2015
      • Vol. 18  (2) , 122-9
    Open Access

    Characterization of inhibitory effects of the potential therapeutic inhibitors, benzoic acid and pyridine derivatives, on the monophenolase and diphenolase activities of tyrosinase.

    by Nematollah Gheibi, Negar Taherkhani, Abolfazl Ahmadi, Kamahldin Haghbeen, Dariush Ilghari

    Involvement of tyrosinase in the synthesis of melanin and cell signaling pathway has made it an attractive target in the search for therapeutic inhibitors for treatment of different skin hyperpigmentation disorders and melanoma cancers. In the present study, we conducted a comprehensive kinetic analysis to understand the mechanisms of inhibition imposed by 2-amino benzoic acid, 4-amino benzoic acid, nicotinic acid, and picolinic acid on the monophenolase and diphenolase activities of the mushroom tyrosinase, and then MTT assay was exploited to evaluate their toxicity on the melanoma cells. Kinetic analysis revealed that nicotinic acid and picolinic acid competitively restricted the monophenolase activity with inhibition constants (Ki) of 1.21 mM and 1.97 mM and the diphenolase activity with Kis of 2.4 mM and 2.93 mM, respectively. 2-aminobenzoic acid and 4-aminobenzoic acid inhibited the monophenolase activity in a non-competitive fashion with Kis of 5.15 µM and 3.8 µM and the diphenolase activity with Kis of 4.72 µM and 20 µM, respectively. Our cell-based data revealed that only the pyridine derivatives imposed cytotoxicity in melanoma cells. Importantly, the concentrations of the inhibitors leading to 50% decrease in the cell density (IC50) were comparable to those causing 50% drop in the enzyme activity, implying that the observed cytotoxicity is highly likely due to the tyrosinase inhibition. Moreover, our cell-based data exhibited that the pyridine derivatives acted as anti-proliferative agents, perhaps inducing cytotoxicity in the melanoma cells through inhibition of the tyrosinase activities.


  • Open Access

    Novel Real Time Polymerase Chain Reaction Approach for Rapid Detection of the Residual Escherichia coli Genomic DNA in Biopharmaceutical Products Establishment of Real Time Polymerase Chain Reaction to Detect Residual gDNA

    by Taghi Naserpour Farivar, Babak Mamnoon, Mohsen Karimi Arzenani, Dariush Ilghari

    Background: Contamination of therapeutic recombinant proteins with residual host cell DNA must be controlled under the regulatory standards. Objectives: The current study established a new rapid, sensitive real time polymerase chain reaction (PCR) approach to measure the reliably of the residual Escherichia coli (E. coli) host cell genomic DNA in the recombinant streptokinase and alfa interferon preparations. Materials and Methods: In this assay, a specific primer pair was utilized to amplify a 115 base pair sequence inside the E. coli 16S rRNA using SYBR Green Chemistry. This method enabled the authors to detect a very small quantity of the residual genomic DNA, as low as 0.8 pg, in the protein-based drugs. This method can, therefore, offer a dependable way to quantitatively analyze the major contaminant of biopharmaceutical products, the host cell DNA, during the manufacturing process. Results: SYBR Green PCR master mix may contain a source of DNA contamination during its manufacturing process. Conclusions: The current study data showed that E. coli host cell DNA contamination in streptokinase and alfa interferon manufactured in the Pasteur institute of Iran is much lower than the safety limits suggested by the FDA. Keywords: Streptokinase; Alfa interferon; Real Time PCR

  • Open Access

    Cloning and Expression of Mycobacterium Tuberculosis Rv0285 (Pe5) Gene

    by Majid Sirati-Sabet, Mehdi Sahmani, Reza Najafipour, Safarali Alizadeh, Hossein Piri, Zohreh Abdolvahabi, Farhad Khabbaz, Dariush Ilghari

    Background: PE5 is a member of the PE protein family whose precise function is yet to be understood. There are about 100 members of the PE family proteins in mycobacterium tuberculosis. These glycine- and alanine-rich proteins consist of Proline-Glutamate motifs at their N-termini and may be implicated in pathogenesis of the bacilli. Objectives: We aimed to clone and over-express the Rv0285 coding region in the BL21 (DE3) Escherichia coli strain for the future functional investigations. Materials and Methods: The PE5 coding region was cloned into a specific vector containing N-terminal GST tag using ligation independent cloning (LIC) method and then the recombinant vector was transferred into the competent TOP10 E. coli strain. The positive colonies were screened by the colony PCR approach and finally integration of the constructed expression vector was assessed by DNA sequencing. The vectors were then transferred and expressed in E. coli BL21 (DE3) strain and finally the protein expression level was analyzed using SDS-PAGE. Results: In this study, the PE5 (Rv0285) coding region was amplified as a 309 bp DNA fragment from the mycobacterium tuberculosis H37Rv chromosome using specific sets of primers. The amplicon was then cloned into pLEICS-02 and then confirmed by DNA sequencing. The recombinant protein was over-expressed as a ~ 40 kDa tagged protein in E. coli, and finally confirmed by SDS-PAGE analysis. Conclusions: Our data showed that recombinant PE5 coding region was successfully cloned in pLEICS-02 and expressed in BL21 (DE3) E. coli strain as host. Keywords: Mycobacterium Tuberculosis; Genes